Poonai, N. ., Mehrotra, S. ., Mamdani, M. ., Patmanidis, A. ., Miller, M. ., Sukhera, J. ., & Doan, Q. . (2018). The association of exposure to suicide-related Internet content and emergency department visits in children: A population-based time series analysis. Canadian Journal of Public Health = Revue Canadienne De Sante Publique, 108(5-6), e462-e467. (Original work published 2018)

Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., Ketchum, S. ., … REDUCE-IT, I. . (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)

Ridker, P. ., Revkin, J. ., Amarenco, P. ., Brunell, R. ., Curto, M. ., Civeira, F. ., … Outcome, I. S. C. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376(16), 1527-1539. https://doi.org/10.1056/NEJMoa1701488 (Original work published 2017)

Peck, K. ., Towne, T. ., Wierenga, C. ., Hill, L. ., Eisler, I. ., Brown, T. ., … Kaye, W. . (2021). Temperament-based treatment for young adults with eating disorders: acceptability and initial efficacy of an intensive, multi-family, parent-involved treatment. Journal of Eating Disorders, 9(1), 110. https://doi.org/10.1186/s40337-021-00465-x (Original work published 2021)

Verma, S. ., Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., … REDUCE-IT, I. . (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)